- $20.99m
- -$35.56m
- $48.82m
- 58
- 99
- 37
- 70
2019 June 30th | R2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K/A | 10-K/A | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4.92 | 27.8 | 34.8 | 40.7 | 48.8 |
Cost of Revenue | |||||
Gross Profit | 0.652 | 25.1 | 33.4 | 40.7 | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 51.2 | 53.5 | 95.2 | 116 | 85.6 |
Operating Profit | -46.2 | -25.7 | -60.4 | -75.5 | -36.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -16.8 | -47.2 | -41.3 | -54.5 | -31.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16.8 | -47.2 | -41.3 | -54.5 | -31.8 |
Net Income Before Extraordinary Items | |||||
Net Income | -16.8 | -47.2 | -41.3 | -54.5 | -31.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -16.8 | -47.2 | -41.3 | -54.5 | -31.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -4.73 | -10.3 | -7.34 | -8.75 | -4.78 |